ARCP Volume Alert - ARCP 8.63 American Realty Capital

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
ARCP Volume Alert - ARCP 8.63 American Realty Capital Propert $ARCP Hit a high of 8.67 Currently 11:15 Last price 8.63 +0.13 +1.53% With a day low of 8.45 and a current volume of 3,610,216.

ARCP American Realty Capital Propert Recent Headline News

Report: Nearly 40K reps and advisers stop selling Schorsch non-traded REITs
Seeking Alpha - at Seeking Alpha - 5 mins ago

RCAP: 11.02 (+0.35), ARCP: 8.59 (+0.09)

American Realty Capital Properties: A Buy Even Though It Might Get Worse Before It Gets Better
Reuben Gregg Brewer - at Seeking Alpha - Tue Nov 11, 1:35AM CST

ARCP: 8.59 (+0.09)

ARCP: Friday's Commentary Helps Bull Case
Orange Peel Investments - at Seeking Alpha - Mon Nov 10, 6:19PM CST

ARCP: 8.59 (+0.09)

Most active Nasdaq-traded stocks
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
ACHN: 12.96 (+0.11), DNDN: 0.16 (-0.02), CMCSK: 51.93 (-0.90), ARCP: 8.59 (+0.09), MSFT: 48.83 (-0.06), INTC: 33.31 (+0.05), CMCSA: 52.10 (-0.85), AAPL: 108.83 (unch), CSCO: 25.18 (+0.03)

Why I Doubled My Position In American Realty Capital Properties Last Week
The Owl - Seeking Alpha - Sun Nov 09, 1:19PM CST
Full Disclosure: I hold a sizeable position in American Realty Capital Properties ( ARCP ). Background: It is not news to investors who follow ARCP that there has been a considerable amount of concern about the value of ARCP, following...
ARCP: 8.59 (+0.09)

Going Against The Grain With American Realty Capital Properties
Charles Lewis Sizemore, CFA - at Seeking Alpha - Fri Nov 07, 7:25PM CST
American Realty Capital Properties (NASDAQ: ARCP ) is a company that will give you heartburn. Since news of its accounting scandal broke last week, it’s lost nearly 40% of its value. But these are precisely the kinds of situations that...
ARCP: 8.59 (+0.09)

Upcoming Investor Conferences, Survey Results, Corporate Statement, and Third Quarter Results - Research Reports on Visa, Simon, Goldman Sachs, ARCP and Umpqua
PR Newswire - Fri Nov 07, 8:20AM CST
Today, Analysts Review released its research reports regarding Visa Inc. (NYSE: V), Simon Property Group Inc. (NYSE: SPG), The Goldman Sachs Group, Inc. (NYSE: GS), American Realty Capital Properties, Inc. (NASDAQ: ARCP) and Umpqua Holdings Corporation (NASDAQ: UMPQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7793-100free.
UMPQ: 17.90 (-0.05), RCAP: 11.02 (+0.35), GS: 192.10 (+0.30), V: 249.13 (-1.08), SPG: 180.74 (-1.53), ARCP: 8.59 (+0.09)

ARCP: The Ultimate Black Friday Buy?
Dave Koppenheffer, The Motley Fool - Motley Fool - Fri Nov 07, 7:22AM CST
American Capital Realty Property has gotten into the Black Friday spirit early this year as its stock price has been slashed 35% over the last week. On October 29, the company reported it had overstated adjusted funds from operations, or AFFO, --...
RCAP: 11.02 (+0.35), O: 46.96 (-0.14), ARCP: 8.59 (+0.09)

Why I Haven't Sold My ARCP Shares... Yet
Nicholas Ward - at Seeking Alpha - Thu Nov 06, 4:55PM CST

RCAP: 11.02 (+0.35), NNN: 38.26 (-0.67), ARCP: 8.59 (+0.09), O: 46.96 (-0.14), DRI: 55.69 (+1.38)

Dividend Update - October 2014
Passive Income Pursuit - Seeking Alpha - Thu Nov 06, 2:35PM CST
October was a big drop from September's record-setting month, but that was completely expected. I did set a personal best for dividend payments in the first month of a quarter, though. These dividend updates reflect all dividends that I receive...
KO: 42.66 (+0.27), PM: 88.01 (-0.41), GE: 26.27 (-0.20), MDT: 69.04 (+0.33), JPM: 61.67 (-0.26), BAX: 70.86 (+0.23), EOG: 97.95 (-0.55), O: 46.96 (-0.14), ARCP: 8.59 (+0.09)

REITs: 5 Lowest-Price, High-Yield Issues Boast 51.43% Edge
Fredrik Arnold - at Seeking Alpha - Thu Nov 06, 1:41PM CST

STAG: 24.36 (+0.07), GOV: 23.16 (-0.20), SIR: 24.21 (-0.03), ARR: 3.98 (-0.01), HPT: 30.08 (-0.19), WMC: 14.97 (-0.03), WHLR: 4.37 (unch), ARCP: 8.59 (+0.09), SNH: 22.33 (-0.01), CORR: 7.34 (-0.12)

Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Thu Nov 06, 8:11AM CST
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
HBNK: 19.80 (+0.02), ESYS: 17.28 (-0.06), DRIV: 24.54 (-0.23), AVIV: 33.22 (-0.07), SAPE: 24.66 (+0.01), ARCP: 8.59 (+0.09), CVD: 100.60 (-0.27)

Dividend Income Update - October 2014
Dividend Mantra - Seeking Alpha - Wed Nov 05, 6:22PM CST
Another month has passed by, and it's time for me to post an article on my favorite subject: dividend income. The reason why I love to post articles on dividend income is because it's pure numbers. It's hard to argue the success of long-term dividend...
KO: 42.66 (+0.27), GE: 26.27 (-0.20), MDT: 69.04 (+0.33), RTN: 103.67 (+0.15), SYY: 38.68 (+0.03), MO: 49.48 (-0.39), BNS: 60.49 (+0.59), ITW: 93.01 (-0.06), PM: 88.01 (-0.41), BAX: 70.86 (+0.23), ARCP: 8.59 (+0.09)

American Realty Capital - Enough Already, Thoughts From A Shareholder
Rubicon Associates - Seeking Alpha - Wed Nov 05, 2:15PM CST
The lunacy of American Realty Capital (NASDAQ: ARCP ) continues. A brief recap of the exciting week that ARCP shareholders (myself included) have had: ARCP's audit committee discloses that Q1 and Q2 2014 results were misstated - AFFO adjustment...
RCAP: 11.02 (+0.35), ARCP: 8.59 (+0.09)

Top 10 REITs Air Yield, Upside, And Net Gain For November
Fredrik Arnold - at Seeking Alpha - Wed Nov 05, 12:33PM CST

RSO: 5.17 (-0.01), SIR: 24.21 (-0.03), AHH: 9.39 (+0.04), IRT: 9.83 (+0.04), AHT: 11.37 (-0.04), HPT: 30.08 (-0.19), GLPI: 31.75 (+0.03), SNH: 22.33 (-0.01), STAG: 24.36 (+0.07), GOV: 23.16 (-0.20), APTS: 8.70 (-0.04), ARR: 3.98 (-0.01), WMC: 14.97 (-0.03), WHLR: 4.37 (unch), ARCP: 8.59 (+0.09), ORC: 14.17 (+0.37), CORR: 7.34 (-0.12)

Lifshitz & Miller Law Firm Announces Investigation of American Realty Capital Properties Inc., Covance Inc., Elecsys Corporation, ESB Financial Corporation, Hudson Valley Holding Corp., Monarch Community Bancorp, Inc., and Penford Corporation
PR Newswire - Wed Nov 05, 12:22PM CST
American Realty Capital Properties Inc.
ESBF: 18.89 (+0.06), ESYS: 17.28 (-0.06), PENX: 18.78 (-0.02), HVB: 26.00 (unch), ARCP: 8.59 (+0.09), CVD: 100.60 (-0.27)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading